文献速递乳腺外科

黑色素瘤前哨淋巴结阳性后观察策略的复发模式与区域控制

Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
PubMed 文献 · Br J Surg · 2020-06-02

BACKGROUND: Two RCTs found no survival benefit for completion lymphadenectomy after positive sentinel lymph node biopsy compared with observation with ultrasound in patients with melanoma.…

要点

  • 原发灶溃疡、无病间期≤12个月及特定复发模式与复发后生存降低相关。

核心结论

  • 前哨淋巴结阳性后观察策略区域控制良好,可评估复发时间与模式,并避免淋巴结清扫相关并发症。

研究设计与样本

  • 单中心回顾性数据库研究(1995-2018年),纳入370例前哨淋巴结阳性且未立即行完成性淋巴结清扫的黑色素瘤患者。

主要发现

  • 仅淋巴结首次复发者3年复发后黑色素瘤特异性生存率为73%(95%CI 54-86),全身首次复发者为51%(95%CI 31-68)。

临床怎么用

  • 前哨淋巴结阳性黑色素瘤患者可选择观察策略,避免立即完成性淋巴结清扫。
  • 随访中需监测区域淋巴结及局部移行复发,必要时行治疗性淋巴结清扫。
  • 原发灶溃疡、无病间期短及特定复发模式提示复发后预后较差,应加强随访。

局限性

  • 单中心回顾性研究,可能存在选择偏倚。
  • 中位随访33个月,可能不足以评估晚期复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two RCTs found no survival benefit for completion lymphadenectomy after positive sentinel lymph node biopsy compared with observation with ultrasound in patients with melanoma. Recurrence patterns and regional control are not well described for patients undergoing observation alone. METHODS: All patients with a positive sentinel node biopsy who did not have immediate completion lymphadenectomy were identified from a single-institution database (1995-2018). First recurrences were classified as node only, local and in-transit (LCIT) only, LCIT and nodal, or systemic. Regional control and factors associated with recurrence survival were analysed. RESULTS: Median follow-up was 33 months. Of 370 patients, 158 (42·7 per cent) had a recurrence. The sites of first recurrence were node only (13·2 per cent), LCIT only (11·9 per cent), LCIT and nodal (3·5 per cent), and systemic (13·8 per cent). The 3-year postrecurrence melanoma-specific survival rate was 73 (95 per cent c.i. 54 to 86) per cent for patients with node-only first recurrence, and 51 (31 to 68) per cent for those with initial systemic recurrence. In multivariable analysis, ulceration in the primary lesion (hazard ratio (HR) 2·53, 95 per cent c.i. 1·27 to 5·04), disease-free interval 12 months or less (HR 2·38, 1·28 to 4·35), and systemic (HR 2·57, 1·16 to 5·65) or LCIT and nodal (HR 2·94, 1·11 to 7·79) first recurrence were associated significantly with decreased postrecurrence survival. Maintenance of regional control required therapeutic lymphadenectomy in 13·0 per cent of patients during follow-up. CONCLUSION: Observation after a positive sentinel lymph node biopsy is associated with good regional control, permits assessment of the time to and pattern of recurrence, and spares lymphadenectomy-related morbidity in patients with melanoma.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Bartlett EK, Lee AY, Spanheimer PM, et al. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. Br J Surg. 2020. PMID: 32484242. doi:10.1002/bjs.11621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。